BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 56 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $95,000 | -4.0% | 63,075 | +23.3% | 0.00% | 0.0% |
Q4 2015 | $99,000 | -2.0% | 51,175 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $101,000 | -4.7% | 51,175 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $106,000 | -10.2% | 51,175 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $118,000 | +2.6% | 51,175 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $115,000 | +42.0% | 51,175 | +57.0% | 0.00% | – |
Q3 2014 | $81,000 | +24.6% | 32,594 | +43.2% | 0.00% | – |
Q2 2014 | $65,000 | -50.4% | 22,761 | +6.6% | 0.00% | -100.0% |
Q1 2014 | $131,000 | -17.1% | 21,361 | -43.3% | 0.00% | 0.0% |
Q4 2013 | $158,000 | +0.6% | 37,661 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $157,000 | +20.8% | 37,661 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $130,000 | – | 37,661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 729,781 | $2,080,000 | 1.97% |
Healthcare Value Capital, LLC | 145,507 | $415,000 | 0.35% |
Broadfin Capital, LLC | 2,244,266 | $6,396,000 | 0.32% |
TOWERVIEW LLC | 225,000 | $641,000,000 | 0.31% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 360,668 | $1,028,000 | 0.22% |
Dominick & Dominick LLC | 146,016 | $416,000 | 0.20% |
BVF INC/IL | 435,900 | $1,242,000 | 0.20% |
Perceptive Advisors | 253,400 | $722,000 | 0.07% |
BAILARD, INC. | 115,000 | $328,000 | 0.05% |
KNOTT DAVID M | 88,100 | $251,085,000 | 0.04% |